Abstract:BACKGROUND: Hepatitis B virus (HBV) is a hepatotropic, noncytopathic, DNA virus which can cause acute and chronic infection. Viral persistence is associated with a weak or absent specific immune responses to HBV, particularly the cellular immune response. Dendritic cells (DCs) are professional antigen-presenting cells with a unique T cell stimulatory aptitude that play a crucial role in the instruction of adaptive immune responses upon infection. An impaired function of DCs was suggested by recent studies to account for the T and B cell hyporesponsiveness in chronic HBV infection. This review summarizes recent insights into the recognition of HBV antigens by DCs. DATA SOURCES: Studies were identified by searching MEDLINE and/or PubMed for articles using the key words "hepatitis B virus (HBV)", "dendritic cells", "C-type lectins", "mannose receptor", "toll-like receptor", and "dendritic cell-specific intercellular-adhesion-molecule-3 grabbing nonintegrin (DC-SIGN)" up to December 2009. Additional papers were identified by a manual search of the references from the key articles. RESULTS: DCs play an important role in the progress of hepatitis B, especially in the recognition of HBV. There are three main ways of recognition of HBV antigens by DCs. First, HBV DNA can be recognized by DCs through toll-like receptor 9 (TLR9) which activates the NF-kappa B signal pathway and p38 MAPK to up-regulate the expression of interferon (IFN) regulatory factor 7 (IRF-7) in a manner independent of type I IFN signaling, resulting in secretion of type I IFN and inflammatory cytokines, and induction of DC maturation and the adaptive immune response. Second, HBc/HBeAg cannot be recognized by DCs, but DNA or ssRNA encapsulated within HBcAg can be internalized by DCs through TLRs. Third, HBsAg can be internalized by DCs through the mannose receptor, which lacks the ability to induce DC maturation without the assistance of DC-SIGN. Meanwhile, there is some cross-talk among the three mechanisms, which induces an effective anti-viral response or HBV persistence. CONCLUSIONS: On the basis of these recognition processes, methods have been used to enhance the efficacy of DC-based vaccine against HBV and have been useful in the clinical application of HBV vaccine therapy. But the interactions between HBV antigens/HBV DNA and DCs are not clear, and cross-talk between TLRs and various ligands makes HBV antigen recognition by DCs more complicated. More efforts should be made to define the mechanisms and develop effective vaccines and therapies. (Hepatobiliary Pancreat Dis Int 2010; 9:584-592)

Mechanism of Human Papillomavirus Infection on the Dendritic Cells

Influence of Human Papillomavirus E7 Oncoprotein on Maturation and Function of Plasmacytoid Dendritic Cells in Vitro

Toll-Like Receptors in Human Papillomavirus Infection

Human papillomavirus infection and host innate immune responses

Ubiquitination in Host Immune Response to Human Papillomavirus Infection

Human Papillomavirus Infection and Host Immune Response

Engagement of Programmed Cell Death 1 and Its Ligands in Human Papillomaviurs Related Diseases

Tlr Agonists Activate Hpv11 E7-Pulsed Dcs to Promote A Specific T Cell Response in A Murine Model

Toll Like Receptor Agonists Augment HPV 11 E7-specific T Cell Responses by Modulating Monocyte-Derived Dendritic Cells

Advances on Autophagy and Human Papillomavirus

Role of dendritic cells in host immunity to herpes simplex virus and possible mechanisms

Induction of Co-Inhibitory Molecule CTLA-4 by Human Papillomavirus E7 Protein Through Downregulation of Histone Methyltransferase JHDM1B Expression

Autophagy is Induced in Human Keratinocytes During Human Papillomavirus 11 Pseudovirion Entry

The Mechanisms Used by Human Papillomavirus to Escape the Host Immune Response

Recognition of HBV antigens and HBV DNA by dendritic cells.

Papillomavirus-like Particles Stimulate Murine Bone Marrow-Derived Dendritic Cells to Produce Alpha Interferon and Th1 Immune Responses Via MyD88.

Reseach Progress on Human Papillomavirus and Its Related Carcinogenesis

Advances of Research on the Carcinogenesis of Human Papillomavirus

Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity

Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.

APOBEC-mediated Genomic Alterations Link Immunity and Viral Infection During Human Papillomavirus-Driven Cervical Carcinogenesis